We have found that patients with neurologic manifestations of #COVID19 have inflammatory cytokines in their CSF, at levels approaching that of CAR T cell neurotoxicity. What’s more, this can be detected weeks after the acute infection. Role for steroids?
https://t.co/ueCvRLHGE9
Clinical Reasoning: A 59-Year-Old Woman Presenting With Diplopia, Dysarthria, Right-Sided Weakness, and #Encephalopathy https://t.co/lZgvp0CbWB #NeurologyRF
May is #BrainTumorAwarenessMonth. Dr. Ingo Mellinghoff, Chair of MSK's Dept. of #Neurology, has devoted his career to studying how cancer affects the brain. See what he thinks are the most promising advances for #BrainCancer in the near future. #NeuroOnc https://t.co/KgLi68AXOQ
Excited to announce this labor of love is published. Our look at the current state and future of CNS #lymphoma trials. Thanks to my collaborators @OHSUSOM and @sloan_kettering #PCNSL#Neurotwitter https://t.co/VVChYp7xtU
@YochaiReemMD Good question! I suspect the CSF cytokine elevation is more closely linked to systemic CRS severity than to cancer, based on our matched CoV- controls. Selecting for milder patients and smaller cytokine panels (we used a 92-marker assay) might also explain reporting differences.
We have found that patients with neurologic manifestations of #COVID19 have inflammatory cytokines in their CSF, at levels approaching that of CAR T cell neurotoxicity. What’s more, this can be detected weeks after the acute infection. Role for steroids?
https://t.co/ueCvRLHGE9
@winstoncb Unclear. Drawing from our experience managing CAR T cell neurotoxicity, tocilizumab (an IL-6 receptor blocker) improves systemic cytokine release but does NOT improve neurotoxicity; in fact it worsens neurologic outcomes. Most biologics also don't cross the blood brain barrier.
@ahandvanish All had at least a mild dysexecutive syndrome or "brain fog." A subset experienced additional specific neurologic symptoms: severe prolonged delirium following intubation, limbic encephalitis, headaches, seizures, etc.
It's International #WomenInSTEM Day! RT and join us as we celebrate and give a virtual high-five 🖐 to our incredible female scientists, researchers, doctors, nurses, and staff, who work tirelessly every day to further cancer research, care, and education.
#WomenInScience
Discussed in this week's episode: A team led by Dr. Viviane Tabar (@TabarViviane) at @sloan_kettering has generated large-scale cryopreserved dopamine progenitors for clinical use in the treatment of #ParkinsonsDisease.
📖 Read the paper here: https://t.co/CWQs0K1atd